Literature DB >> 22634386

Comparing participation rates between immunochemical and guaiac faecal occult blood tests: a systematic review and meta-analysis.

Gemma Vart1, Rita Banzi, Silvia Minozzi.   

Abstract

BACKGROUND: Biennial screening with faecal occult blood tests (FOBts) has been found to reduce colorectal cancer mortality. Faecal immunochemical tests (FITs) are superior to guaiac faecal occult blood tests (G-FOBts) due to their improved sensitivity and specificity. However the effectiveness of a screening programme depends highly on participation rates. The aim of this study was to review studies comparing guaiac faecal occult blood tests and faecal immunochemical tests, in terms of participation rates.
METHODS: We searched PubMed and the Cochrane Library (2000-September 2011) to identify randomised control trials comparing guaiac faecal occult blood test with faecal immunochemical test participation rates. One author screened the titles and abstracts, and performed data extraction which was then checked by the other authors. Risk of bias in the included studies was also assessed.
RESULTS: Seven studies met the eligibility criteria and were entered into a meta-analysis. Participation rates were significantly higher for individuals offered faecal immunochemical tests compared to those offered a guaiac faecal occult blood test (RR 1.21; 95% CI 1.09-1.33). Potential factors that could have influenced participation were discussed.
CONCLUSIONS: Colorectal cancer screening programmes currently using guaiac faecal occult blood tests could improve participation rates by converting to faecal immunochemical tests. More research examining the acceptability of faecal immunochemical tests, from a patient perspective, is warranted.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22634386     DOI: 10.1016/j.ypmed.2012.05.006

Source DB:  PubMed          Journal:  Prev Med        ISSN: 0091-7435            Impact factor:   4.018


  33 in total

1.  Uptake and positive predictive value of fecal occult blood tests: A randomized controlled trial.

Authors:  Jessica Chubak; Andy Bogart; Sharon Fuller; Sharon S Laing; Beverly B Green
Journal:  Prev Med       Date:  2013-09-09       Impact factor: 4.018

2.  Screening for Bowel Cancer: Increasing Participation via Personal Invitation.

Authors:  Michael Hoffmeister; Bernd Holleczek; Nadine Zwink; Christian Stock; Christa Stegmaier; Hermann Brenner
Journal:  Dtsch Arztebl Int       Date:  2017-02-10       Impact factor: 5.594

Review 3.  FIT testing: an overview.

Authors:  Lukejohn W Day; Taft Bhuket; James Allison
Journal:  Curr Gastroenterol Rep       Date:  2013-11

Review 4.  Faecal occult blood testing for colorectal cancer screening: the past or the future.

Authors:  Sally C Benton; Helen E Seaman; Stephen P Halloran
Journal:  Curr Gastroenterol Rep       Date:  2015-02

Review 5.  Home-use faecal immunochemical testing: primary care diagnostic technology update.

Authors:  Brian D Nicholson; Matthew Thompson; Christopher P Price; Carl Heneghan; Annette Plüddemann
Journal:  Br J Gen Pract       Date:  2015-03       Impact factor: 5.386

6.  A Systematic Review of Repeat Fecal Occult Blood Tests for Colorectal Cancer Screening.

Authors:  Caitlin C Murphy; Ahana Sen; Bianca Watson; Samir Gupta; Helen Mayo; Amit G Singal
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2019-11-18       Impact factor: 4.254

Review 7.  Recommendations on Fecal Immunochemical Testing to Screen for Colorectal Neoplasia: A Consensus Statement by the US Multi-Society Task Force on Colorectal Cancer.

Authors:  Douglas J Robertson; Jeffrey K Lee; C Richard Boland; Jason A Dominitz; Francis M Giardiello; David A Johnson; Tonya Kaltenbach; David Lieberman; Theodore R Levin; Douglas K Rex
Journal:  Am J Gastroenterol       Date:  2016-10-18       Impact factor: 10.864

8.  Recruiting community health centers into pragmatic research: Findings from STOP CRC.

Authors:  Gloria D Coronado; Sally Retecki; Jennifer Schneider; Stephen H Taplin; Tim Burdick; Beverly B Green
Journal:  Clin Trials       Date:  2015-09-29       Impact factor: 2.486

9.  An automated intervention with stepped increases in support to increase uptake of colorectal cancer screening: a randomized trial.

Authors:  Beverly B Green; Ching-Yun Wang; Melissa L Anderson; Jessica Chubak; Richard T Meenan; Sally W Vernon; Sharon Fuller
Journal:  Ann Intern Med       Date:  2013-03-05       Impact factor: 25.391

Review 10.  Colorectal Cancer Screening in Average Risk Patients.

Authors:  Alison T Brenner; Michael Dougherty; Daniel S Reuland
Journal:  Med Clin North Am       Date:  2017-05-06       Impact factor: 5.456

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.